NanoString Technologies this week announced the appointment of Wayne Cowens as chief medical officer.
Cowens joins NanoString from Genomic Health, where since 2004 he served in a series of senior medical positions, including vice president of clinical oncology. While at Genomic Health, Cowens led the development of the Oncotype Dx product for multi-gene expression profiling in various cancers.
Cowens previously held senior product development and clinical affairs positions at Chiron (now Novartis Vaccines and Diagnostics) and Ribozyme Pharmaceuticals.
NanoString said that Cowens will help drive the development of the company's pipeline of cancer molecular diagnostics based on the nCounter Analysis System.